Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Feasibility Study of a Home Rehabilitative Network to Treat Prolonged Weaned Patients (UTIR)

4 juni 2014 bijgewerkt door: Michele Vitacca, Fondazione Salvatore Maugeri

Feasibility and Efficacy of a Home Rehabilitative Network for Prolonged Weaned Patients Discharged From a Weaning Unit

Patients at high complexity with severe chronic diseases can require several admission in intensive care units (ICU) to overcome acute exacerbations by the use of assisted ventilation. In the last 10 years, new technologies and beds in ICU evidenced a new group of patients often needing weaning procedures due to a long-lasting period of mechanical ventilation. These patients are often under chronic conditions with recurrent symptoms, reduced effort tolerance and depression.

Weaning process is a frail step in the medical history of a patient who has survived an acute episode of respiratory failure and has spent a period of time under mechanical ventilation. Patients are followed for the duration of in-hospital stay, an expected average period of 4 weeks.

When discharged fron an Intensive Care Unit (ICU) or a weaning center, the patient is usually managed by GPs and by the hospital where he has been admitted to following re-exacerbations. The conventional approach is for sure inadequate for this type of patient whose clinical complexity, disability and frailty need for a continuity of care through a higher complex approach of management.

A structured program of Home Rehabilitation could be a possible solution to this problem. Thus, the hypothesis of the study is to evaluate feasibility and sustainability and efficacy of a home rehabilitative network for prolonged weaned patients discharged from a weaning unit.

Studie Overzicht

Gedetailleerde beschrijving

Patients referred to the Fondazione Salvatore Maugeri for prolonged weaning are enrolled and trained in an individualised program of home care in order to recover their own autonomies. Home care compares 2 arms: usual care vs physiotherapist (PT)-assisted care. Usual care consists in supporting drug and oxygen therapy, mechanical ventilation, GP's assistance, periodical in-hospital visit. The PT-assisted home care is supported by PT at least 2 times/month, autonomous 50 min physical activity/working day by the help of a DVD. The physical activity consists in cyclette, calisthenic exercises, and training of the respiratory muscles. Few brief educational lessons by PT preceded the training activity. Every two weeks, PT calls the patient by phone for an educational reinforcement.

Studietype

Ingrijpend

Inschrijving (Werkelijk)

60

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

    • Brescia
      • Lumezzane, Brescia, Italië, 25065
        • Fondazione Salvatore Maugeri

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar en ouder (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

  • General Inclusion criteria: 1. Signature of the informed 2. Good expectation of life
  • Specific Inclusion Criteria : Score of general dependences < 19 according to the Critical Patients Autonomy Planning (CPAP) Scale

Exclusion Criteria:

  • Patient with neuromuscular, highly progressive neurological diseases (i.e. amyotrophic lateral sclerosis), patient requiring surgical interventions, sedation, and hemodialysis.
  • Unstable patient conditions as daily variability of the blood arterial pressure >20%, arrhythmias, PaO2/FiO2 < 300, unsatisfactory respiratory pattern, haemoglobin < 7 g /dL, temperature > 38°C, presence of neurological or orthopaedic side effects, and recent embolisms from TVP. Refusal.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Ondersteunende zorg
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Actieve vergelijker: Usual home care
No assistance or care by PT.
Usual home care consists in supporting drug and oxygen therapy, mechanical ventilation, GP's assistance,and periodical in-hospital visit.
Experimenteel: PT-assisted home rehabilitation
Assisted home care is supported by a PT at least 2 times/month. Few brief educational lessons preceeded the training activity that the patient performs by himself at home.

Patient performs 50 min physical activity/working day autonomously by the help of a DVD. The physical activity consists in cyclette, calisthenic exercises, and training of the respiratory muscles.

Every two weeks, PT phones the patient for an educational reinforcement.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Critical Patients Autonomy Planning (CPAP)
Tijdsspanne: Changes from baseline and 4 weeks, and 6 months after home activity
CPAP is a measure of dependency. CPAP was evaluated at three different time-points: at in-hospital admission (baseline), at discharge (patients are followed for the duration of their in-hospital stay, an expected average time of 4 weeks), and after 6 months of physical activity at home.
Changes from baseline and 4 weeks, and 6 months after home activity

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP)
Tijdsspanne: Changes from baseline and 4 weeks (average time), and 6 months after home activity
Respiratory Functionality
Changes from baseline and 4 weeks (average time), and 6 months after home activity
MRF 26
Tijdsspanne: Changes between discharge at 4 weeks (average time) and 6 months after home activity
Quality of life evaluation.
Changes between discharge at 4 weeks (average time) and 6 months after home activity
Likert Scale
Tijdsspanne: Changes between discharge at 4 weeks (average time) and 6 months after home activity
Satisfaction for patient/caregiver
Changes between discharge at 4 weeks (average time) and 6 months after home activity
Mortality
Tijdsspanne: Changes between 3, 6 and 12 months post-discharge
Clinical measure
Changes between 3, 6 and 12 months post-discharge
MRC Scale and/or dynamometer
Tijdsspanne: Changes between baseline, discharge at 4 weeks, and 6 months after home activity
Rehabilitative measure referring to muscles force
Changes between baseline, discharge at 4 weeks, and 6 months after home activity
6-min walking test
Tijdsspanne: Changes from baseline and discharge at 4 weeks, and 6 months after home activity
Rehabilitative measure evaluating the effort tolerance.
Changes from baseline and discharge at 4 weeks, and 6 months after home activity
EuroQol
Tijdsspanne: Changes between discharge at 4 weeks (average time) and 6 months after home activity
Quality of life evaluation
Changes between discharge at 4 weeks (average time) and 6 months after home activity
Gussago Nursing Scale
Tijdsspanne: Changes from baseline and 4 weeks, and 6 months after home activity
Measure of dependency.
Changes from baseline and 4 weeks, and 6 months after home activity
Barthel Index
Tijdsspanne: Changes from baseline and 4 weeks, and 6 months after home activity
Measure of dependency.
Changes from baseline and 4 weeks, and 6 months after home activity
Pre-morbidity life-style (PLS)
Tijdsspanne: Changes from baseline and 4 weeks, and 6 months after home activity
Measure of dependency.
Changes from baseline and 4 weeks, and 6 months after home activity

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Piero Ceriana, MD, Fondazione Salvatore Maugeri
  • Studie directeur: Michele Vitacca, MD, Fondazione Salvatore Maugeri

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start

1 juli 2011

Primaire voltooiing (Werkelijk)

1 januari 2013

Studie voltooiing (Werkelijk)

1 juli 2013

Studieregistratiedata

Eerst ingediend

10 april 2012

Eerst ingediend dat voldeed aan de QC-criteria

13 april 2012

Eerst geplaatst (Schatting)

16 april 2012

Updates van studierecords

Laatste update geplaatst (Schatting)

5 juni 2014

Laatste update ingediend die voldeed aan QC-criteria

4 juni 2014

Laatst geverifieerd

1 juni 2014

Meer informatie

Termen gerelateerd aan deze studie

Aanvullende relevante MeSH-voorwaarden

Andere studie-ID-nummers

  • UTIR
  • Dlg. 5685 on 28 May 2010 (Ander subsidie-/financieringsnummer: Lombardy Region)

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren